Clinical Trial Update: Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study comparing momelotinib to ruxolitinib in adults with untreated myelofibrosis and low blood counts; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Momelotinib (momelotinib)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Myelofibrosis, Myelofibrosis (MF) | Phase 4 | Status: NOT_YET_RECRUITING